olaparib [Ligand Id: 7519] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL521686 (AZ-2281, AZ2281, AZD-2281, AZD2281, KEYLYNK-010 COMPONENT OLAPARIB, KU-0059436, KU-59436, Lynparza, NSC-747856, Olaparib, OLAPARIB COMPONENT OF KEYLYNK-010) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Mono [ADP-ribose] polymerase PARP16 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105981] [UniProtKB: Q8N5Y8] | ||||||||
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP16 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.29 | pIC50 | 5128.61 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP16 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.29 | pIC50 | 5100 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| poly(ADP-ribose) polymerase 1/Poly [ADP-ribose] polymerase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3105] [GtoPdb: 2771] [UniProtKB: P09874] | ||||||||
| ChEMBL | Binding affinity to human GST-tagged PARP-1 ART domain (788 to 1014 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant incubated for 30 mins by microscale thermophoresis analysis | B | 5.27 | pKd | 5310 | nM | Kd | J Med Chem (2021) 64: 7839-7852 [PMID:34038131] |
| ChEMBL | Binding affinity to recombinant human PARP-1 by SPR analysis | B | 9.51 | pKd | 0.31 | nM | Kd | J Med Chem (2021) 64: 12089-12108 [PMID:34404206] |
| ChEMBL | Binding affinity to recombinant human HisGST-tagged PARP-1 catalytic domain by surface plasmon resonance analysis | B | 9.62 | pKd | 0.24 | nM | Kd | J Med Chem (2015) 58: 6875-6898 [PMID:26222319] |
| ChEMBL | Binding affinity to full length His-tagged PARP1 (unknown origin) after 11 mins in presence of NAD+ by TR-FRET assay | B | 9.1 | pKi | 0.79 | nM | Ki | Medchemcomm (2019) 10: 974-984 [PMID:31303996] |
| ChEMBL | Inhibition of human recombinant GST-tagged PARP-1 expressed in Escherichia coli assessed as reduction in NAD+-dependent ADP ribosylation incubated for 30 mins in presence and NAD by resazurin dye based fluorescence analysis | B | 5.53 | pIC50 | 2960 | nM | IC50 | J Med Chem (2019) 62: 3051-3067 [PMID:30844273] |
| ChEMBL | Inhibition of N-terminal GST-tagged human PARP1 expressed in a Baculovirus infected Sf9 insect cells using biotinylated substrate incubated for 1 hr by colorimetric method | B | 6.86 | pIC50 | 139 | nM | IC50 | Bioorg Med Chem (2019) 27: 3979-3997 [PMID:31401008] |
| ChEMBL | Cellular Assay: Based on the preliminary PARP1 inhibition evaluation of compounds at molecular level by ELISA, compounds were further evaluated for their cellular inhibition against PARP1 using a proliferation inhibition model. | B | 7.06 | pIC50 | 86.32 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | Inhibition of human PARP1 | B | 7.07 | pIC50 | 84.96 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 3739-3743 [PMID:25086680] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP1 C-3-zinc finger domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 7.16 | pIC50 | 69.18 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | ELISA Assay: The HTb-PARP1 positive clones were obtained using the full-length PARP1 plasmid, through PCR amplification, enzyme digestion, ligation, and transformation into DH5a. The plasmids were extracted and determined by enzyme cleavage, and then transformed into DH10Bac. Bacmid/PARP is determined by PCR and sequencing. TNI was transfected, the viruses were collected, and cells were lysed. PARP1 protein was purified by affinity chromatography and determined by Western blotting. A plate was coated by substrate histone, NAD+ and DNA, as well as expressed PARP1 enzyme, was placed into 96-well plate reaction system. Various reaction conditions were optimized and ultimately determined. | B | 7.3 | pIC50 | <50 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | ELISA Assay: The HTb-PARP1 positive clones were obtained using the full-length PARP1 plasmid, through PCR amplification, enzyme digestion, ligation, and transformation into DH5a. The plasmids were extracted and determined by enzyme cleavage, and then transformed into DH10Bac. Bacmid/PARP is determined by PCR and sequencing. TNI was transfected, the viruses were collected, and cells were lysed. PARP1 protein was purified by affinity chromatography and determined by Western blotting. A plate was coated by substrate histone, NAD+ and DNA, as well as expressed PARP1 enzyme, was placed into 96-well plate reaction system. Various reaction conditions were optimized and ultimately determined. | B | 7.37 | pIC50 | 43 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | Inhibition of recombinant human full length C-terminal His-tagged PARP1 expressed in Sf9 insect cells preincubated for 15 mins followed by NAD+ addition and measured after 40 mins by fluorescence based assay | B | 7.44 | pIC50 | 36 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1904-1908 [PMID:31153806] |
| ChEMBL | Inhibition of PARP1 (unknown origin) assessed as reduction in biotinylated poly(ADP-ribose) incorporation on to histone protein by ELISA based colorimetric assay | B | 7.7 | pIC50 | 20 | nM | IC50 | Eur J Med Chem (2017) 138: 1135-1146 [PMID:28763648] |
| ChEMBL | Inhibition of PARP1 (unknown origin) by ELISA | B | 7.72 | pIC50 | 19.1 | nM | IC50 | Eur J Med Chem (2017) 138: 514-531 [PMID:28692916] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP1 C-3-zinc finger domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 7.72 | pIC50 | 18.9 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of PARP-1 (unknown origin) assessed as incorporation of biotinylated poly ADP-ribose onto histone proteins by colorimetric analysis in presence of GSH and GSTP1 | B | 7.81 | pIC50 | 15.5 | nM | IC50 | J Med Chem (2014) 57: 2292-2302 [PMID:24521039] |
| ChEMBL | In Vitro Screening Assay: PARP-1 can catalyze the NAD-dependent addition of poly (ADP-ribose) to adjacent nuclear proteins such as histone. The activity of PARP was determined by detecting biotin coupled ADP-ribose that attaches to histone using chemiluminescence method with HT Universal Chemiluminescent PARP Assay Kit With Histone-coated Strip Wells purchased from TREVIGEN. The positive control compound was AZD-2281 purchased from SelleckChem.Method: The kit is based on ELISA. X ul sample/well, Y ul PARP enzyme/well and PARP cocktail 25 ul/well with a total volume of 50 ul/well were added into a 96-well plate coated with histone. Meanwhile, blank control (without enzyme and sample) and negative control (without sample) were set. The plate was incubated at room temperature for 60 min; washed with 1xPBS (+0.1% TritonX-100) for twice; Strep-HRP 50 ul/well was added and incubated at room temperature for 60 min; and then washed with 1xPBS (+0.1% TritonX-100) for twice. | B | 7.92 | pIC50 | 12 | nM | IC50 | US-9187430-B2. Poly (ADP-ribose) polymerase inhibitor (2015) |
| ChEMBL | Inhibition of PARP1 (unknown origin) incubated for 10 mins using biotinylated NAD+ and activated DNA by colorimetric assay | B | 7.92 | pIC50 | 11.9 | nM | IC50 | J Med Chem (2015) 58: 8683-8693 [PMID:26469301] |
| ChEMBL | Inhibition of recombinant human PARP1 using histone as substrate after 1 hr in presence of NAD+ by ELISA | B | 7.96 | pIC50 | 11 | nM | IC50 | Eur J Med Chem (2018) 145: 389-403 [PMID:29335205] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP1 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 7.99 | pIC50 | 10.23 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of GST-tagged recombinant human PARP-1 expressed in Escherichia coli after 30 mins by fluorescence-based assay | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 462-466 [PMID:24388690] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP1 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of human PARP1 expressed in Escherichia coli incubated for 10 mins by colorimetric assay | B | 8.08 | pIC50 | 8.39 | nM | IC50 | Bioorg Med Chem (2019) 27: 3979-3997 [PMID:31401008] |
| ChEMBL | Inhibition of recombinant human PARP-1 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA | B | 8.09 | pIC50 | 8.1 | nM | IC50 | Bioorg Med Chem (2017) 25: 4045-4054 [PMID:28622906] |
| ChEMBL | Inhibition of PARP-1 (unknown origin) using biotinylated NAD+ as substrate after 60 mins by spectrophotometry | B | 8.15 | pIC50 | 7 | nM | IC50 | J Med Chem (2014) 57: 5579-5601 [PMID:24922587] |
| ChEMBL | Inhibition of human recombinant PARP-1 after 1 hr by ELISA | B | 8.22 | pIC50 | 6 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 2669-2673 [PMID:24815508] |
| ChEMBL | Ex vivo inhibition of PARP1 in human SW620 cells assessed as amount of poly(ADP-ribose) by whole cell assay | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2008) 51: 6581-6591 [PMID:18800822] |
| ChEMBL | Binding affinity to PARP1 in human OVCAR8 cells assessed as reduction in [125I]-KX1 binding by gamma counting analysis | B | 8.22 | pIC50 | 6 | nM | IC50 | J Med Chem (2018) 61: 5367-5379 [PMID:29856625] |
| ChEMBL | Inhibition of human PARP1 catalytic activity after 10 mins by ELISA | B | 8.22 | pIC50 | 6 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4501-4505 [PMID:23850199] |
| ChEMBL | Inhibition of PARP-1 (unknown origin) | B | 8.28 | pIC50 | 5.22 | nM | IC50 | Bioorg Med Chem Lett (2021) 31: 127710-127710 [PMID:33246105] |
| ChEMBL | Inhibition of recombinant human full-length PARP-1 using biotinylated substrate | B | 8.29 | pIC50 | 5.1 | nM | IC50 | J Med Chem (2021) 64: 12089-12108 [PMID:34404206] |
| ChEMBL | Inhibition of recombinant human PARP1 using histone as substrate after 1 hr in presence of biotinylated NAD+ by ELISA | B | 8.3 | pIC50 | 5.01 | nM | IC50 | J Med Chem (2020) 63: 122-139 [PMID:31846325] |
| GtoPdb | Assayed using PARP-1 isolated from HeLa cells, in a scintillation proximity ELISA. | - | 8.3 | pIC50 | 5 | nM | IC50 |
J Med Chem (2008) 51: 6581-91 [PMID:18800822]; J Biomol Screen (2003) 8: 347-52 [PMID:12857389] |
| ChEMBL | Inhibition of PARP1 by flashplate scintillation proximity assay | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2008) 51: 6581-6591 [PMID:18800822] |
| ChEMBL | Inhibition of PARP1 (unknown origin) | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2015) 58: 3302-3314 [PMID:25761096] |
| ChEMBL | Inhibition of PARP1 (unknown origin) | B | 8.3 | pIC50 | 5 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 4127-4132 [PMID:27353531] |
| ChEMBL | Inhibition of PARP1 (unknown origin) | B | 8.3 | pIC50 | 5 | nM | IC50 | WO-2018064237-A1. An elisa-like assay for quantifying enzymatic activities of mono-adp-ribosyltransferases (null) |
| ChEMBL | Inhibition of human PARP-1 catalytic domain (662 to 1011 residues) expressed in Escherichia coli BL21(DE3) cells pre-incubated for 30 mins before addition of activated DNA and NAD by fluorescence based assay | B | 8.32 | pIC50 | 4.8 | nM | IC50 | J Med Chem (2020) 63: 15541-15563 [PMID:33264017] |
| ChEMBL | Inhibition of recombinant human GST-fused PARP-1 expressed in Escherichia coli after 30 mins by fluorescence assay | B | 8.35 | pIC50 | 4.5 | nM | IC50 | Bioorg Med Chem (2014) 22: 1089-1103 [PMID:24398383] |
| ChEMBL | Inhibition of PARP1 (unknown origin) | B | 8.38 | pIC50 | 4.19 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127036-127036 [PMID:32088129] |
| ChEMBL | Inhibition of human recombinant PARP1 after 1 hr by ELISA | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2013) 56: 2885-2903 [PMID:23473053] |
| ChEMBL | Inhibition of recombinant full length human N-terminal GST-tagged PARP1 expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis | B | 8.44 | pIC50 | 3.59 | nM | IC50 | Bioorg Med Chem (2017) 25: 4100-4109 [PMID:28601509] |
| ChEMBL | Inhibition of PARP1 (unknown origin) by colorimetric assay | B | 8.44 | pIC50 | 3.59 | nM | IC50 | Bioorg Med Chem (2019) 27: 3979-3997 [PMID:31401008] |
| ChEMBL | Inhibition of recombinant human PARP1 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA | B | 8.68 | pIC50 | 2.09 | nM | IC50 | Eur J Med Chem (2017) 132: 26-41 [PMID:28340412] |
| ChEMBL | Inhibition of recombinant human PARP1 using NAD+ as substrate incubated for 1 hr by ELISA | B | 8.68 | pIC50 | 2.09 | nM | IC50 | J Med Chem (2021) 64: 16711-16730 [PMID:34748333] |
| ChEMBL | Inhibition of human PARP1 using [3H]NAD as substrate after 1 min by microplate scintillation counting analysis | B | 8.71 | pIC50 | 1.94 | nM | IC50 | J Med Chem (2016) 59: 335-357 [PMID:26652717] |
| ChEMBL | Inhibition of recombinant human full length N-terminal GST- tagged PARP1 expressed in baculovirus infected sf9 cells using Colorimetric HRP as substrate incubated for 30 mins by UV/Vis spectrophotometer analysis | B | 8.74 | pIC50 | 1.8 | nM | IC50 | Eur J Med Chem (2019) 182: 111621-111621 [PMID:31442685] |
| ChEMBL | Inhibition of PARP1 in human G7 cells incubated for 60 mins by immunofluorescence assay | B | 8.8 | pIC50 | 1.6 | nM | IC50 | J Med Chem (2015) 58: 8683-8693 [PMID:26469301] |
| ChEMBL | Inhibition of PARP1 in human T98G cells incubated for 60 mins by immunofluorescence assay | B | 8.8 | pIC50 | 1.6 | nM | IC50 | J Med Chem (2015) 58: 8683-8693 [PMID:26469301] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP1 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 8.85 | pIC50 | 1.4 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP1 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 8.86 | pIC50 | 1.38 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of PARP1 (unknown origin) using biotin-NAD+ as substrate incubated for 1 hr by ELISA | B | 8.9 | pIC50 | 1.26 | nM | IC50 | Eur J Med Chem (2021) 217: 113357-113357 [PMID:33740547] |
| ChEMBL | Inhibition of human full-length N-terminal GST-tagged PARP1 expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2019) 62: 5330-5357 [PMID:31042381] |
| ChEMBL | Inhibition of human full-length N-terminal GST-tagged PARP1 expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay | B | 8.93 | pIC50 | 1.18 | nM | IC50 | J Med Chem (2019) 62: 5330-5357 [PMID:31042381] |
| ChEMBL | Inhibition of PARP1 (unknown origin) | B | 8.96 | pIC50 | 1.1 | nM | IC50 | Bioorg Med Chem Lett (2021) 47: 128169-128169 [PMID:34091044] |
| ChEMBL | Inhibition of full length human PARP1 expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 9 | pIC50 | 1 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5743-5747 [PMID:26546219] |
| ChEMBL | Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested. | B | 9.05 | pIC50 | 0.9 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | Inhibition of N-terminal GST-tagged human full length PARP1 (2 to 1041 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay | B | 9.05 | pIC50 | 0.9 | nM | IC50 | Bioorg Med Chem (2020) 28: 115819-115819 [PMID:33120078] |
| ChEMBL | Inhibition of PARP1 (unknown origin) incubated for 45 mins in presence of biotinylated-NAD+ by microplate reader analysis | B | 9.22 | pIC50 | 0.6 | nM | IC50 | J Med Chem (2021) 64: 17413-17435 [PMID:34813314] |
| ChEMBL | Inhibition of PARP1 in human Jurkat cells assessed as reduction of cell viability after 96 hrs by MTS assay | B | 4.8 | pEC50 | 16000 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 4501-4505 [PMID:23850199] |
| ChEMBL | Inhibition of PARP1 in human Jurkat cells assessed as reduction of cell viability after 96 hrs by MTS assay in presence of 100 uM of temozolomide | B | 7.22 | pEC50 | 60 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 4501-4505 [PMID:23850199] |
| ChEMBL | Inhibition of human PARP-1 catalytic domain (662 to 1011 residues) expressed in Escherichia coli BL21(DE3) cells incubated for 0.5 hrs by fluorescence polarization assay based DNA trapping activity assay | B | 7.8 | pEC50 | 16 | nM | EC50 | J Med Chem (2020) 63: 15541-15563 [PMID:33264017] |
| ChEMBL | Inhibition of PARP-1 in human HeLa cells assessed as decrease of H2O2-induced PARylation after 3 hrs by fluorescence assay | B | 8.6 | pEC50 | 2.5 | nM | EC50 | Bioorg Med Chem (2014) 22: 1089-1103 [PMID:24398383] |
| ChEMBL | Inhibition of PARP-1 in human HeLa cells incubated for 18 hrs in presence of H2O2 | B | 9.4 | pEC50 | 0.4 | nM | EC50 | J Med Chem (2020) 63: 15541-15563 [PMID:33264017] |
| poly(ADP-ribose) polymerase family member 10/Poly [ADP-ribose] polymerase 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2429708] [GtoPdb: 3267] [UniProtKB: Q53GL7] | ||||||||
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP10 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.03 | pIC50 | 9332.54 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP10 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.03 | pIC50 | 9300 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP10 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.9 | pIC50 | 1258.93 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP10 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.9 | pIC50 | 1250 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| Poly [ADP-ribose] polymerase 12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2429709] [UniProtKB: Q9H0J9] | ||||||||
| ChEMBL | Inhibition of recombinant human His6-tagged PARP12 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 4.99 | pIC50 | 10232.93 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP12 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5 | pIC50 | 10050 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| poly(ADP-ribose) polymerase family member 15/Poly [ADP-ribose] polymerase 15 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2176778] [GtoPdb: 3270] [UniProtKB: Q460N3] | ||||||||
| ChEMBL | Inhibition of recombinant human His6-tagged PARP15 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 4.75 | pIC50 | 17782.79 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP15 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 4.75 | pIC50 | 17600 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of N-terminal His-tagged human PARP15 catalytic domain (481 to 678 residues) expressed in Escherichia coli BL21 (DE3) cells up to 100 uM in presence of NAD+ incubated for 2 hrs by M-ELISA plate method | B | 5.1 | pIC50 | 7943.28 | nM | IC50 | WO-2018064237-A1. An elisa-like assay for quantifying enzymatic activities of mono-adp-ribosyltransferases (null) |
| ChEMBL | Inhibition of N-terminal His-tagged human PARP15 catalytic domain (481 to 678 residues) expressed in Escherichia coli BL21 (DE3) cells up to 100 uM in presence of NAD+ incubated for 2 hrs by M-ELISA plate method | B | 5.14 | pIC50 | 7300 | nM | IC50 | WO-2018064237-A1. An elisa-like assay for quantifying enzymatic activities of mono-adp-ribosyltransferases (null) |
| poly(ADP-ribose) polymerase 2/Poly [ADP-ribose] polymerase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5366] [GtoPdb: 2772] [UniProtKB: Q9UGN5] | ||||||||
| ChEMBL | Binding affinity to recombinant human HisGST-tagged PARP-2 catalytic domain by surface plasmon resonance analysis | B | 9.55 | pKd | 0.28 | nM | Kd | J Med Chem (2015) 58: 6875-6898 [PMID:26222319] |
| ChEMBL | Binding affinity to recombinant human PARP-2 by SPR analysis | B | 9.57 | pKd | 0.27 | nM | Kd | J Med Chem (2021) 64: 12089-12108 [PMID:34404206] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.6 | pIC50 | 251.19 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.6 | pIC50 | 251 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 7.91 | pIC50 | 12.3 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 7.91 | pIC50 | 12.3 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA | B | 8.52 | pIC50 | 3 | nM | IC50 | Eur J Med Chem (2018) 145: 389-403 [PMID:29335205] |
| ChEMBL | Inhibition of human PARP2 (2 to 583 residues) expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5743-5747 [PMID:26546219] |
| ChEMBL | Inhibition of PARP2 (unknown origin) | B | 8.55 | pIC50 | 2.81 | nM | IC50 | Bioorg Med Chem (2019) 27: 3979-3997 [PMID:31401008] |
| ChEMBL | Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis | B | 8.55 | pIC50 | 2.81 | nM | IC50 | Bioorg Med Chem (2017) 25: 4100-4109 [PMID:28601509] |
| ChEMBL | Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA | B | 8.65 | pIC50 | 2.26 | nM | IC50 | J Med Chem (2021) 64: 16711-16730 [PMID:34748333] |
| ChEMBL | Inhibition of PARP-2 (unknown origin) | B | 8.73 | pIC50 | 1.87 | nM | IC50 | Bioorg Med Chem Lett (2021) 31: 127710-127710 [PMID:33246105] |
| ChEMBL | Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA | B | 8.77 | pIC50 | 1.7 | nM | IC50 | Bioorg Med Chem (2017) 25: 4045-4054 [PMID:28622906] |
| ChEMBL | Inhibition of recombinant human full-length PARP-2 using biotinylated substrate | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2021) 64: 12089-12108 [PMID:34404206] |
| GtoPdb | Assayed using PARP-2 isolated from HeLa cells, in a scintillation proximity ELISA. | - | 9 | pIC50 | 1 | nM | IC50 |
J Med Chem (2008) 51: 6581-91 [PMID:18800822]; J Biomol Screen (2003) 8: 347-52 [PMID:12857389] |
| ChEMBL | Inhibition of recombinant PARP2 by flashplate scintillation proximity assay | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2008) 51: 6581-6591 [PMID:18800822] |
| ChEMBL | Inhibition of recombinant human PARP2 using histone as substrate after 1 hr in presence of biotinylated NAD+ by ELISA | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2020) 63: 122-139 [PMID:31846325] |
| ChEMBL | Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay | B | 9.3 | pIC50 | 0.5 | nM | IC50 | J Med Chem (2019) 62: 5330-5357 [PMID:31042381] |
| ChEMBL | Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested. | B | 9.35 | pIC50 | 0.45 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay | B | 9.4 | pIC50 | 0.4 | nM | IC50 | J Med Chem (2020) 63: 15541-15563 [PMID:33264017] |
| ChEMBL | Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay | B | 9.4 | pIC50 | 0.4 | nM | IC50 | J Med Chem (2019) 62: 5330-5357 [PMID:31042381] |
| poly (ADP-ribose) polymerase 3/Poly [ADP-ribose] polymerase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5083] [GtoPdb: 2864] [UniProtKB: Q9Y6F1] | ||||||||
| GtoPdb | - | - | 8.24 | pKd | 5.8 | nM | Kd | J Med Chem (2021) 64: 14498-14512 [PMID:34570508] |
| ChEMBL | Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested. | B | 6.49 | pIC50 | 320 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP3 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.64 | pIC50 | 230 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of full length recombinant human His6-tagged PARP3 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.64 | pIC50 | 229.09 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of PARP3 (unknown origin) using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 7.34 | pIC50 | 46 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5743-5747 [PMID:26546219] |
| Poly [ADP-ribose] polymerase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6142] [UniProtKB: Q9UKK3] | ||||||||
| ChEMBL | Inhibition of recombinant human His6-tagged PARP4 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.39 | pIC50 | 410 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human His6-tagged PARP4 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.39 | pIC50 | 407.38 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| Poly [ADP-ribose] polymerase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2380187] [UniProtKB: Q2NL67] | ||||||||
| ChEMBL | Inhibition of full length human PARP6 expressed in a Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 5.74 | pIC50 | 1800 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5743-5747 [PMID:26546219] |
| tankyrase/Tankyrase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6164] [GtoPdb: 3108] [UniProtKB: O95271] | ||||||||
| ChEMBL | Inhibition of human recombinant TNKS in DLD1-Wnt-Luc cells after 20 to 22 hrs by luciferase reporter assay | B | 5.45 | pIC50 | 3534 | nM | IC50 | Medchemcomm (2015) 6: 1687-1692 |
| ChEMBL | Inhibition of human TNKS1 (1001 to 1327 residues) expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 5.72 | pIC50 | 1900 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5743-5747 [PMID:26546219] |
| ChEMBL | Inhibition of human N-terminal GST-tagged TNKS1 (1001 to 1327 residues) expressed in baculovirus infected sf9 cells using histone as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 5.74 | pIC50 | 1800 | nM | IC50 | J Med Chem (2018) 61: 5367-5379 [PMID:29856625] |
| ChEMBL | Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested. | B | 5.77 | pIC50 | 1700 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| ChEMBL | Inhibition of histidine-tagged recombinant tankyrase-1 by flashplate scintillation proximity assay | B | 5.82 | pIC50 | 1500 | nM | IC50 | J Med Chem (2008) 51: 6581-6591 [PMID:18800822] |
| ChEMBL | Inhibition of recombinant human TNKS1 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.91 | pIC50 | 1230.27 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human TNKS1 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.91 | pIC50 | 1230 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested. | B | 7.98 | pIC50 | 10.4 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
| tankyrase 2/Tankyrase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6154] [GtoPdb: 3109] [UniProtKB: Q9H2K2] | ||||||||
| ChEMBL | Inhibition of recombinant human TNKS2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.63 | pIC50 | 2344.23 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of recombinant human TNKS2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5.63 | pIC50 | 2340 | nM | IC50 | J Med Chem (2017) 60: 1262-1271 [PMID:28001384] |
| ChEMBL | Inhibition of human TNKS2 (667 to 1166 residues) expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 5.77 | pIC50 | 1700 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 5743-5747 [PMID:26546219] |
| ChEMBL | Inhibition of human N-terminal GST-tagged TNKS2 (667 to 1166 residues) expressed in baculovirus infected sf9 cells using histone as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay | B | 5.92 | pIC50 | 1200 | nM | IC50 | J Med Chem (2018) 61: 5367-5379 [PMID:29856625] |
| ChEMBL | Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested. | B | 8.28 | pIC50 | 5.2 | nM | IC50 | US-9255106-B2. Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors (2016) |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
